← All Anterix INC filings

Anterix INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
ATEX
Anterix INC
SCHEDULE: T. Rowe Price Discloses 12% Stake in Anterix Inc.
T. Rowe Price Investment Management, Inc. has reported beneficial ownership of 12.0% of Anterix Inc.'s common stock as of June 30, 2026.
NASDAQ
ATEX
Anterix INC
SCHEDULE: Vanguard Trims Anterix Stake to Just Under 5%
The Vanguard Group has reported a 4.97% beneficial ownership stake in Anterix Inc. following an internal realignment.
NASDAQ
ATEX
Anterix INC
SCHEDULE: DG Capital Management Discloses 4% Stake in Anterix
DG Capital Management, LLC and Dov Gertzulin have reported a 4.0% beneficial ownership stake in Anterix Inc., holding 744,544 shares of common stock.
NASDAQ
ATEX
Anterix INC
SCHEDULE: BlackRock Reports 5.1% Stake in Anterix Inc.
BlackRock, Inc. has reported an updated beneficial ownership of 5.1% in Anterix Inc., holding 950,842 shares of common stock as of September 30, 2025.
NASDAQ
ATEX
Anterix INC
SCHEDULE: DG Capital Management Discloses 5.2% Stake in Anterix
DG Capital Management and Dov Gertzulin have disclosed a passive 5.2% beneficial ownership stake in Anterix Inc., totaling 975,739 shares.